AKUMS DRUGS & PHARMACEUTICALS
|
|
| BOM : 544222     NSE : AKUMS     | |
| LT :  
    Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive] Debt : High |
Updated: |
| ST :  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Mild Upward Pledged Shares : None or < 25% |
Dec 19,2025 |
|
Price(EOD): ₹ 427.60
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
|
Pharmaceuticals & Drugs |
| MCap: ₹ 6,730.42 Cr | |
| Industry Peers & Returns | 1W | 1M | 1Y |
| AKUMS DRUGS & PHARMACEUTICALS | 1.2% | 1.4% | -27.2% |
| SUN PHARMACEUTICAL INDUSTRIES | -2.9% | -1.8% | -2.5% |
| DIVIS LABORATORIES | 2.1% | 0.2% | 9.1% |
| CIPLA | 0.7% | -0.8% | 3.4% |
| TORRENT PHARMACEUTICALS | 0.5% | 2.2% | 11.2% |
| DR REDDYS LABORATORIES | -0.1% | 2.5% | 2.5% |
| MANKIND PHARMA | 1.5% | -2.8% | -19.5% |
| ZYDUS LIFESCIENCES | -0.2% | -0.8% | -5.7% |
| LUPIN | 1.7% | 4.7% | 3.5% |
FUNDAMENTAL ANALYSIS OF AKUMS DRUGS & PHARMACEUTICALS
 Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
VALUATION OF AKUMS DRUGS & PHARMACEUTICALS
 | Ratio | Consolidated | |
|---|---|---|
|
P/E P/B P/S |
20.82
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 323.30 Cr
[Latest Qtr - Sep2025 - Consolidated Results ] 2.21
P/B Calculated based on Book Value of Rs 3,047.01 Cr
[Latest Year - Mar2025 - Consolidated Results ] 1.64
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 4,107.52 Cr
[Latest Qtr - Sep2025 - Consolidated Results ] |
|
| Financial Ratios → | ||
| Model | Discount(-)/ Premium(+) |
|---|---|
|
EV/EBIDTA EV/Sales Price/Sales |
NA 19425% - |
SHARE PRICE MOMENTUM OF AKUMS DRUGS & PHARMACEUTICALS
AKUMS DRUGS & PHARMACEUTICALS vs SENSEX
DEBT OF AKUMS DRUGS & PHARMACEUTICALS
| Year | Debt/Equity ratio | |
|---|---|---|
| Standalone | Consolidated | |
|
2025 2024 2023 Avg_3yrs |
0 1.57 0.47 0.68 |
0 0.69 0.75 0.48 |
|
[Last Annual Data : Mar2025]
|
||
| Financial Ratios → | ||
PLEDGED PROMOTER SHARES OF AKUMS DRUGS & PHARMACEUTICALS
| Pledged Promoter Shares |
0 % | |
|---|---|---|
| As on : Sep2025 | ||
If less than 25% | Good |
|
| If between 25% and 50% | Neutral | |
| If greater than 50% | Bad | |
| Shareholding Pattern → | ||
QTRLY RESULTS OF AKUMS DRUGS & PHARMACEUTICALS
| Consolidated | Q-o-Q | Y-o-Y |
|---|---|---|
|
Revenue Op Profit Profit Before Tax Profit After Tax |
-0.63% -26.75% -31.34% -33.99% |
-1.51% -22.04% -28.29% -35.94% |
| QtrlyTrend |
-8 | |
| Latest Qtr: Sep2025 | ||
| Quarterly Result Analysis → | ||
AKUMS DRUGS & PHARMACEUTICALS related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| BSE ALLCAP | 6.4% | 8.9% | 7.5% |
| BSE MIDSMALLCAP | 4.7% | 9% | 8.4% |
| BSE SMALLCAP | -0.2% | -3.8% | -11.2% |
| BSE HEALTHCARE | -0.3% | -1.6% | -0.5% |
| NSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| NIFTY SMALLCAP 250 | 0.1% | -3.2% | -10.6% |
| NIFTY MIDSMALLCAP 400 | NA | -1.9% | -3.2% |
| NIFTY 500 EQUAL WEIGHT | -0.1% | -2.6% | -4.7% |
| NIFTY500 LARGEMIDSMALL EQUAL-CAP WEIGHTED INDEX | -0.1% | -1.6% | -2% |
| NIFTY500 MULTICAP 50:25:25 | -0.1% | -1.4% | -0.7% |
You may also like the below Video Courses
FAQ about AKUMS DRUGS & PHARMACEUTICALS
Is AKUMS DRUGS & PHARMACEUTICALS good for long term investment?
As on Dec 19,2025, the Fundamentals of AKUMS DRUGS & PHARMACEUTICALS look Average and hence you may wait for the results to improve to invest for long term ! See Financial Performance of AKUMS DRUGS & PHARMACEUTICALS . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!Is AKUMS DRUGS & PHARMACEUTICALS UnderValued or OverValued?
As on Dec 19,2025, AKUMS DRUGS & PHARMACEUTICALS is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!What is the Intrinsic Value of AKUMS DRUGS & PHARMACEUTICALS ?
As on Dec 19,2025, the Intrinsic Value of AKUMS DRUGS & PHARMACEUTICALS is Rs. 2.19 estimated based on Median of the 3 historical models.Fair Value [Median EV / EBIDTA Model] : Rs. -8.93
Fair Value [Median EV / Sales Model] : Rs. 2.19
Fair Value [Median Price / Sales Model] : Rs. 0.00
Estimated Median Fair Value of AKUMS DRUGS & PHARMACEUTICALS : Rs. 2.19
The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.